Cereno Scientific AB (publ) (FRA:4A1)
Germany flag Germany · Delayed Price · Currency is EUR
0.7805
+0.1330 (20.54%)
At close: Dec 1, 2025

Cereno Scientific AB Statistics

Total Valuation

FRA:4A1 has a market cap or net worth of EUR 230.02 million. The enterprise value is 239.69 million.

Market Cap230.02M
Enterprise Value 239.69M

Important Dates

The last earnings date was Thursday, November 27, 2025.

Earnings Date Nov 27, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 294.59M
Shares Outstanding n/a
Shares Change (YoY) -4.55%
Shares Change (QoQ) +0.49%
Owned by Insiders (%) 9.75%
Owned by Institutions (%) 23.41%
Float 249.41M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 54.50
PB Ratio 13.10
P/TBV Ratio 14.10
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -23.39
EV / Sales 56.39
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -22.33

Financial Position

The company has a current ratio of 4.34, with a Debt / Equity ratio of 0.93.

Current Ratio 4.34
Quick Ratio 4.25
Debt / Equity 0.93
Debt / EBITDA n/a
Debt / FCF -1.52
Interest Coverage -1.78

Financial Efficiency

Return on equity (ROE) is -53.34% and return on invested capital (ROIC) is -13.07%.

Return on Equity (ROE) -53.34%
Return on Assets (ROA) -12.33%
Return on Invested Capital (ROIC) -13.07%
Return on Capital Employed (ROCE) -19.43%
Revenue Per Employee 422,013
Profits Per Employee -1.02M
Employee Count10
Asset Turnover 0.13
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +38.06% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +38.06%
50-Day Moving Average 0.70
200-Day Moving Average 0.74
Relative Strength Index (RSI) 70.05
Average Volume (20 Days) 200

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:4A1 had revenue of EUR 4.22 million and -10.25 million in losses. Loss per share was -0.04.

Revenue4.22M
Gross Profit 4.22M
Operating Income -6.58M
Pretax Income -10.25M
Net Income -10.25M
EBITDA -6.51M
EBIT -6.58M
Loss Per Share -0.04
Full Income Statement

Balance Sheet

The company has 6.71 million in cash and 16.32 million in debt, giving a net cash position of -9.61 million.

Cash & Cash Equivalents 6.71M
Total Debt 16.32M
Net Cash -9.61M
Net Cash Per Share n/a
Equity (Book Value) 17.56M
Book Value Per Share 0.06
Working Capital 5.40M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.49 million and capital expenditures -241,192, giving a free cash flow of -10.73 million.

Operating Cash Flow -10.49M
Capital Expenditures -241,192
Free Cash Flow -10.73M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -155.94% and -242.82%.

Gross Margin 100.00%
Operating Margin -155.94%
Pretax Margin -242.82%
Profit Margin -242.82%
EBITDA Margin -154.26%
EBIT Margin -155.94%
FCF Margin n/a

Dividends & Yields

FRA:4A1 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 4.55%
Shareholder Yield 4.55%
Earnings Yield -4.46%
FCF Yield -4.67%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:4A1 has an Altman Z-Score of 5.41 and a Piotroski F-Score of 1.

Altman Z-Score 5.41
Piotroski F-Score 1